If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 329.50
Bid: 328.00
Ask: 329.50
Change: 6.50 (2.01%)
Spread: 1.50 (0.457%)
Open: 328.50
High: 329.50
Low: 322.50
Prev. Close: 323.00
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

4 Nov 2022 07:00

RNS Number : 2795F
Morgan Advanced Materials PLC
04 November 2022
 

 

Press Release

Morgan Advanced Materials plc

4 November 2022

Trading Update

Morgan Advanced Materials plc, the global manufacturer of advanced carbon and ceramic materials for complex and technologically demanding applications, announces today its scheduled trading update for the first nine months to 30 September 2022.

Current Trading

Sales for the nine months to September 2022 were 10.5% higher for the Group, on an organic constant-currency basis, compared with the same period last year.

By business unit, organic constant-currency sales performance for the nine months to September 2022, compared with the same period last year, were as follows:

Thermal Ceramics +10.7%

Molten Metal Systems +17.4%

Electrical Carbon +7.2%

Seals and Bearings +6.9%

Technical Ceramics +13.0%

Group +10.5%

Outlook

Our revenue growth has remained robust. Despite having seen the expected slight moderation of growth rates in our third quarter, reflecting challenges in the wider economy, we now expect our full year organic constant-currency growth to be in the range 7-9%, above our previous guidance. We expect adjusted operating profit for full year 2022 to be marginally above the top end of current analysts' forecasts.

Pete Raby, Chief Executive Officer, said:

"We are delivering robust revenue growth, despite the challenging environment, and improving profitability, with inflation continuing to be more than offset by pricing and continuous improvement activity".

Upcoming events

A capital markets event for institutional investors and analysts will be held on 6 December 2022 in London. Pete Raby and Richard Armitage will be joined by senior leaders from across the group for a series of presentations covering our strategic progress, faster growing market opportunities, ESG approach and the group's financial and M&A framework and aspirations. The slides will be available on the group's website.

The full year results are expected to be released on 28 February 2023.

For further enquiries:

Pete Raby Morgan Advanced Materials plc 01753 837000

Richard Armitage

Nina Coad Brunswick 0207 404 5959

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDXLFBLFLBFBX
Date   Source Headline
15th Nov 20225:06 pmRNSDirector/PDMR Shareholding
10th Nov 20228:03 amRNSDirector Declaration
4th Nov 20227:00 amRNSTrading Update
17th Oct 20222:21 pmRNSDirector/PDMR Shareholding
26th Sep 202212:52 pmRNSDirector/PDMR Shareholding
26th Sep 202212:49 pmRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSHalf-year results
15th Jun 20229:30 amRNSBlock listing Interim Review
1st Jun 202210:00 amRNSDirector/PDMR Shareholding
31st May 202210:06 amRNSDirector/PDMR Shareholding
24th May 20222:32 pmRNSDirector/PDMR Shareholding
16th May 20222:52 pmRNSDirector/PDMR Shareholding
5th May 20223:12 pmRNSDirectorate Change
5th May 20222:00 pmRNSResult of AGM
5th May 20227:00 amRNSQ1 trading update
3rd May 20222:45 pmRNSHolding in Company
14th Apr 20222:59 pmRNSHolding(s) in Company
30th Mar 20223:25 pmRNSAnnual Financial Report
28th Mar 202212:00 pmRNSHolding in Company
23rd Mar 202211:02 amRNSDirector/PDMR Shareholding
23rd Mar 202211:01 amRNSDirector/PDMR Shareholding
22nd Mar 20225:04 pmRNSDirector/PDMR Shareholding
4th Mar 20227:00 amRNSFull-year results
10th Jan 202211:30 amRNSHolding(s) in Company
15th Dec 202110:00 amRNSBlock listing Interim Review
7th Dec 202112:30 pmRNSHolding in Company
26th Nov 20213:32 pmRNSDirector/PDMR Shareholding
23rd Nov 20212:00 pmRNSDirector/PDMR Shareholding
5th Nov 20217:00 amRNSTrading Update
18th Oct 202112:21 pmRNSDirector/PDMR Shareholding
18th Oct 202112:20 pmRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSCFO Appointment
14th Oct 20219:15 amRNSHolding in Company
11th Oct 202110:45 amRNSHolding in Company
28th Sep 20213:15 pmRNSDirector/PDMR Shareholding
17th Sep 20213:58 pmRNSDirector/PDMR Shareholding
16th Sep 202111:30 amRNSDirector/PDMR Shareholding
5th Aug 20211:39 pmRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSHalf-year Results
15th Jun 20219:38 amRNSBlock Listing Interim Review
10th Jun 20219:18 amRNSDirector/PDMR Shareholding
27th May 20214:02 pmRNSDirector/PDMR Shareholding
25th May 20213:38 pmRNSDirector/PDMR Shareholding
11th May 202110:20 amRNSDirector/PDMR Shareholding
6th May 202111:54 amRNSResult of AGM
6th May 20217:00 amRNSDirectorate Change
6th May 20217:00 amRNSTrading Update
31st Mar 20212:08 pmRNSAnnual Financial Report
26th Mar 20219:54 amRNSHolding(s) in Company
24th Mar 202110:10 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.